Flortaucipir tau PET imaging in semantic variant primary progressive aphasia

ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer’...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurology, neurosurgery and psychiatry Vol. 89; no. 10; pp. 1024 - 1031
Main Authors Makaretz, Sara J, Quimby, Megan, Collins, Jessica, Makris, Nikos, McGinnis, Scott, Schultz, Aaron, Vasdev, Neil, Johnson, Keith A, Dickerson, Bradford C
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.10.2018
BMJ Publishing Group
SeriesResearch paper
Subjects
Online AccessGet full text
ISSN0022-3050
1468-330X
1468-330X
DOI10.1136/jnnp-2017-316409

Cover

Loading…
Abstract ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer’s disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.MethodsFTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.ResultsAll seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.ConclusionsIn this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology.
AbstractList The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer's disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.OBJECTIVEThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer's disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.FTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.METHODSFTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.All seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.RESULTSAll seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.In this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology.CONCLUSIONSIn this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology.
The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer's disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [ F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls. FTP and [ C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction. All seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status. In this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology.
ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and is only rarely due to a primary tauopathy or Alzheimer’s disease. We undertook this study to investigate the localisation and magnitude of the presumed tau Positron Emission Tomography (PET) tracer [18F]Flortaucipir (FTP; also known as T807 or AV1451) in patients with svPPA, hypothesising that most patients would not show tracer uptake different from controls.MethodsFTP and [11C]Pittsburgh compound B PET imaging as well as MRI were performed in seven patients with svPPA and in 20 controls. FTP signal was analysed by visual inspection and by quantitative comparison to controls, with and without partial volume correction.ResultsAll seven patients showed elevated FTP uptake in the anterior temporal lobe with a leftward asymmetry that was not observed in healthy controls. This elevated FTP signal, largely co-localised with atrophy, was evident on both visual inspection and quantitative cortical surface-based analysis. Five patients were amyloid negative, one was amyloid positive and one has an unknown amyloid status.ConclusionsIn this series of patients with clinical profiles, structural MRI and amyloid PET imaging typical for svPPA, FTP signal was unexpectedly elevated with a spatial pattern localised to areas of atrophy. This raises questions about the possible off-target binding of this tracer to non-tau molecules associated with neurodegeneration. Further investigation with autopsy analysis will help illuminate the binding target(s) of FTP in cases of suspected FTLD-TDP neuropathology.
Author Makaretz, Sara J
Dickerson, Bradford C
Johnson, Keith A
Collins, Jessica
McGinnis, Scott
Schultz, Aaron
Vasdev, Neil
Quimby, Megan
Makris, Nikos
AuthorAffiliation 1 Frontotemporal Disorders Unit, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA
5 Alzheimer’s Disease Research Center, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA
3 Center for Alzheimer Research and Treatment, Department of Neurology , Brigham and Women’s Hospital , Boston , Massachusetts , USA
2 Center for Morphometric Analysis, Department of Psychiatry , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA
6 Division of Nuclear Medicine and Molecular Imaging, Department of Radiology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA
4 Martinos Center for Biomedical Imaging , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA
AuthorAffiliation_xml – name: 1 Frontotemporal Disorders Unit, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA
– name: 4 Martinos Center for Biomedical Imaging , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA
– name: 6 Division of Nuclear Medicine and Molecular Imaging, Department of Radiology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA
– name: 2 Center for Morphometric Analysis, Department of Psychiatry , Massachusetts General Hospital and Harvard Medical School , Charlestown , Massachusetts , USA
– name: 5 Alzheimer’s Disease Research Center, Department of Neurology , Massachusetts General Hospital and Harvard Medical School , Boston , Massachusetts , USA
– name: 3 Center for Alzheimer Research and Treatment, Department of Neurology , Brigham and Women’s Hospital , Boston , Massachusetts , USA
Author_xml – sequence: 1
  givenname: Sara J
  surname: Makaretz
  fullname: Makaretz, Sara J
  email: brad.dickerson@mgh.harvard.edu
  organization: Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA
– sequence: 2
  givenname: Megan
  surname: Quimby
  fullname: Quimby, Megan
  email: brad.dickerson@mgh.harvard.edu
  organization: Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA
– sequence: 3
  givenname: Jessica
  surname: Collins
  fullname: Collins, Jessica
  email: brad.dickerson@mgh.harvard.edu
  organization: Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA
– sequence: 4
  givenname: Nikos
  surname: Makris
  fullname: Makris, Nikos
  email: brad.dickerson@mgh.harvard.edu
  organization: Center for Morphometric Analysis, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA
– sequence: 5
  givenname: Scott
  surname: McGinnis
  fullname: McGinnis, Scott
  email: brad.dickerson@mgh.harvard.edu
  organization: Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Boston, Massachusetts, USA
– sequence: 6
  givenname: Aaron
  surname: Schultz
  fullname: Schultz, Aaron
  email: brad.dickerson@mgh.harvard.edu
  organization: Alzheimer’s Disease Research Center, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
– sequence: 7
  givenname: Neil
  surname: Vasdev
  fullname: Vasdev, Neil
  email: brad.dickerson@mgh.harvard.edu
  organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
– sequence: 8
  givenname: Keith A
  surname: Johnson
  fullname: Johnson, Keith A
  email: brad.dickerson@mgh.harvard.edu
  organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
– sequence: 9
  givenname: Bradford C
  surname: Dickerson
  fullname: Dickerson, Bradford C
  email: brad.dickerson@mgh.harvard.edu
  organization: Alzheimer’s Disease Research Center, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28986472$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1rGzEUFCUlcdLeeyoLvQTCtvr-uBSCcdKCITmk0JvQrrW2zK60lXYN-ffRYqckPiS6PIk3M2_05hyc-OAtAF8Q_I4Q4T-23vclhkiUBHEK1QcwQ5TLkhD49wTMIMS4JJDBM3Ce0hZOR6pTcIalkpwKPAPLmzbEwYy1610s8qW4XzwUrjNr59eF80WynfGDq4udiS7fij7mbnzMNayjTcntbGH6jUnOfAIfG9Mm-_lQL8Cfm8XD_Fe5vLv9Pb9elhXDfCiJII1ApKGUSpJ9rKAxihO5EsZAuKqkJUIIjAhlrFEc5qeqFJaCMa5oQ8gF-LnX7ceqs6va-iGaVh-c6WCcft3xbqPXYaeZyluiLAtcHgRi-DfaNOjOpdq2rfE2jEkjRfM0ReQ069sRdBvG6PP3NEaIIQoFoRn19aWj_1aeF50BfA-oY0gp2kbXbjCDC5NB12oE9ZSonhLVU6J6n2gmwiPis_YblKs9peq276OfACo9sIw
CitedBy_id crossref_primary_10_1007_s00259_021_05401_4
crossref_primary_10_1093_brain_awab392
crossref_primary_10_2217_nmt_2017_0057
crossref_primary_10_1001_jamaneurol_2023_2560
crossref_primary_10_3389_fneur_2018_00070
crossref_primary_10_1212_WNL_0000000000005112
crossref_primary_10_1007_s00259_022_05963_x
crossref_primary_10_1016_j_jalz_2018_02_018
crossref_primary_10_1016_j_nicl_2019_101889
crossref_primary_10_1016_j_neurobiolaging_2018_02_015
crossref_primary_10_1007_s00259_018_4075_3
crossref_primary_10_1007_s00259_019_04631_x
crossref_primary_10_1016_j_neurobiolaging_2018_11_017
crossref_primary_10_1016_j_arr_2024_102375
crossref_primary_10_1136_jnnp_2019_322402
crossref_primary_10_1002_acn3_683
crossref_primary_10_1186_s13195_023_01176_y
crossref_primary_10_1097_WCO_0000000000001035
crossref_primary_10_1001_jamaneurol_2019_4284
crossref_primary_10_1002_ana_26479
crossref_primary_10_1016_j_praneu_2021_03_011
crossref_primary_10_1093_braincomms_fcae075
crossref_primary_10_1016_S1474_4422_21_00341_0
crossref_primary_10_3390_brainsci12020146
crossref_primary_10_1007_s00259_022_06065_4
crossref_primary_10_1186_s13195_019_0470_7
crossref_primary_10_1093_braincomms_fcad305
crossref_primary_10_1016_j_ncl_2019_08_003
crossref_primary_10_1212_WNL_0000000000006913
crossref_primary_10_1016_j_imu_2024_101551
crossref_primary_10_1002_dad2_12348
crossref_primary_10_3390_ijms232112867
crossref_primary_10_1093_brain_awab057
crossref_primary_10_3390_diagnostics13162687
crossref_primary_10_1007_s11604_019_00881_9
crossref_primary_10_1186_s13195_019_0483_2
crossref_primary_10_1007_s00415_020_10040_0
crossref_primary_10_1055_s_0040_1715134
crossref_primary_10_2967_jnumed_120_244061
crossref_primary_10_1109_ACCESS_2020_2989396
crossref_primary_10_1016_j_jalz_2019_02_004
crossref_primary_10_1038_s41598_019_42625_9
crossref_primary_10_1016_j_nicl_2020_102369
crossref_primary_10_1001_jamaneurol_2020_0989
crossref_primary_10_3390_brainsci11040433
crossref_primary_10_1002_alz_12356
crossref_primary_10_1016_j_cortex_2022_05_010
crossref_primary_10_3389_fneur_2020_00080
crossref_primary_10_1126_scitranslmed_aaw1993
crossref_primary_10_1007_s11277_024_10920_y
crossref_primary_10_3389_fnins_2024_1342928
crossref_primary_10_17340_jkna_2019_1_1
crossref_primary_10_3390_brainsci12070843
crossref_primary_10_1093_brain_awaa276
crossref_primary_10_14412_2074_2711_2019_1_4_11
crossref_primary_10_31363_2313_7053_2024_853
crossref_primary_10_1093_brain_awaa033
crossref_primary_10_12688_f1000research_20330_1
crossref_primary_10_1016_j_neurobiolaging_2020_04_010
crossref_primary_10_1111_ene_15603
crossref_primary_10_1002_ana_25183
crossref_primary_10_1053_j_semnuclmed_2020_12_004
crossref_primary_10_1016_j_neuropsychologia_2020_107391
crossref_primary_10_1007_s00401_024_02801_2
crossref_primary_10_1007_s00415_019_09530_7
crossref_primary_10_1007_s00415_018_8815_x
crossref_primary_10_1007_s13311_021_01101_x
crossref_primary_10_1097_WCO_0000000000000792
crossref_primary_10_3389_fnins_2018_00585
crossref_primary_10_3389_fnagi_2018_00230
crossref_primary_10_1016_j_neuron_2019_08_037
crossref_primary_10_1093_brain_awaa383
crossref_primary_10_1212_CON_0000000000001506
Cites_doi 10.1038/srep16404
10.1002/ana.24885
10.1093/cercor/bhg087
10.1212/WNL.0b013e3181ea15e8
10.1007/s00401-013-1089-6
10.1007/s00401-011-0845-8
10.1177/0271678X16683695
10.1212/WNL.0b013e31821103e6
10.1002/ana.24844
10.2967/jnumed.116.175273
10.1136/jnnp-2013-306948
10.1186/s13195-017-0253-y
10.1002/ana.24517
10.1093/brain/aww313
10.1001/jamaneurol.2016.5755
10.1016/j.jalz.2016.01.003
10.1056/NEJMra022435
10.1093/brain/awp248
10.1016/j.neuroimage.2016.02.042
10.1056/NEJMcpc1613459
10.1007/s00401-016-1618-1
10.1093/brain/aww027
10.1016/j.neuropsychologia.2009.04.011
10.1093/brain/aww163
10.1093/brain/awm213
10.1186/s40478-016-0315-6
10.1002/ana.24546
10.2967/jnumed.115.170027
10.1007/s00401-012-1055-8
10.1007/s00401-008-0460-5
10.1212/WNL.0000000000000431
10.1001/jamaneurol.2016.3338
10.1016/j.neuron.2016.01.028
10.1097/WAD.0b013e31824a7df4
10.1016/j.neuroimage.2006.01.021
10.1002/jlcr.3098
10.1093/brain/115.6.1783
ContentType Journal Article
Copyright Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018
Copyright_xml – notice: Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
– notice: 2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
88G
88I
8AF
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
M0S
M1P
M2M
M2P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1136/jnnp-2017-316409
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
BMJ Journals
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest One Psychology

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-330X
EndPage 1031
ExternalDocumentID PMC5964045
28986472
10_1136_jnnp_2017_316409
jnnp
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
Pittsburgh Pennsylvania
GeographicLocations_xml – name: United States--US
– name: Pittsburgh Pennsylvania
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: P30 AG062421
– fundername: NIA NIH HHS
  grantid: P01 AG036694
– fundername: NIA NIH HHS
  grantid: P50 AG005134
– fundername: NINDS NIH HHS
  grantid: R21 NS077059
– fundername: NIA NIH HHS
  grantid: R01 AG046396
– fundername: NIA NIH HHS
  grantid: R21 AG051987
– fundername: NIBIB NIH HHS
  grantid: P41 EB015896
– fundername: NCRR NIH HHS
  grantid: S10 RR023043
– fundername: NIDCD NIH HHS
  grantid: R01 DC014296
– fundername: NCRR NIH HHS
  grantid: S10 RR021110
– fundername: ;
GroupedDBID ---
.55
.GJ
.VT
0R~
18M
29L
2WC
354
39C
3O-
4.4
40O
41~
53G
5GY
5RE
5VS
7RV
7X7
7~S
88E
88I
8AF
8FI
8FJ
8R4
8R5
9YT
AAHLL
AAKAS
AAOJX
AAUVZ
AAWJN
AAWTL
ABAAH
ABIVO
ABJNI
ABKDF
ABMQD
ABOCM
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACMMV
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADFRT
ADUGQ
ADZCM
AEKJL
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AI.
AJYBZ
AKKEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZFZN
AZQEC
BAWUL
BENPR
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
DWQXO
E3Z
EBS
EJD
EX3
F5P
FEDTE
FYUFA
GNUQQ
GX1
H13
HAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
IPY
ITC
J5H
KQ8
L7B
M1P
M2M
M2P
N9A
NAPCQ
NTWIH
NXWIF
O9-
OK1
OMB
OMG
OVD
P2P
PCD
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
R53
RHI
RMJ
RPM
RV8
SJN
TEORI
TR2
UKHRP
UPT
UYXKK
V24
VH1
VM9
VVN
W8F
WH7
WOW
X7M
YFH
YQT
YQY
ZGI
AAYXX
ACQHZ
ADGHP
AERUA
CITATION
PHGZM
3V.
CGR
CUY
CVF
ECM
EIF
NPM
PKN
RHF
YCJ
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-b526t-373f713f44483864d0aa9638d7aa00db8e3777213455f960e379b928755694f33
IEDL.DBID 9YT
ISSN 0022-3050
1468-330X
IngestDate Thu Aug 21 18:12:53 EDT 2025
Fri Jul 11 16:49:03 EDT 2025
Fri Jul 25 22:15:17 EDT 2025
Wed Feb 19 02:30:16 EST 2025
Thu Apr 24 22:56:41 EDT 2025
Tue Jul 01 01:21:40 EDT 2025
Thu Apr 24 23:06:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords temporallobe
semantic dementia
brain atrophy
primary progressive aphasia
tau PET
Language English
License This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0
Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b526t-373f713f44483864d0aa9638d7aa00db8e3777213455f960e379b928755694f33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://dx.doi.org/10.1136/jnnp-2017-316409
PMID 28986472
PQID 2115140734
PQPubID 2041879
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5964045
proquest_miscellaneous_1948759383
proquest_journals_2115140734
pubmed_primary_28986472
crossref_citationtrail_10_1136_jnnp_2017_316409
crossref_primary_10_1136_jnnp_2017_316409
bmj_primary_10_1136_jnnp_2017_316409
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-10-01
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationSeriesTitle Research paper
PublicationTitle Journal of neurology, neurosurgery and psychiatry
PublicationTitleAlternate J Neurol Neurosurg Psychiatry
PublicationYear 2018
Publisher BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Shoup, Yokell, Rice 2013
Schöll, Carter, Westman 2015; 5
Shcherbinin, Schwarz, Joshi 2016; 57
Marquié, Normandin, Vanderburg 2015; 78
Robinson, Geser, Stieber 2013; 125
Sapolsky, Bakkour, Negreira 2010; 75
Greve, Salat, Bowen 2016; 132
Josephs, Whitwell, Tacik 2016; 132
Mackenzie, Neumann, Bigio 2009; 117
Xia, Makaretz, Caso 2017; 74
Fischl, van der Kouwe, Destrieux 2004; 14
Mesulam, Dickerson, Sherman 2017; 376
Johnson, Schultz, Betensky 2016; 79
Mesulam 2003; 349
Ng, Pascoal, Mathotaarachchi 2017; 9
Halabi, Halabi, Dean 2013; 27
Spinelli, Mandelli, Miller 2017; 81
Desikan, Ségonne, Fischl 2006; 31
Ossenkoppele, Schonhaut, Schöll 2016; 139
Gorno-Tempini, Hillis, Weintraub 2011; 76
Marquié, Normandin, Meltzer 2017; 81
Schöll, Lockhart, Schonhaut 2016; 89
Coakeley, Cho, Koshimori 2016; 271678X
Sander, Lashley, Gami 2016; 12
Hodges, Patterson, Oxbury 1992; 115
Smith, Puschmann, Schöll 2016; 139
Baker, Lockhart, Price 2017; 58
Crawford, Garthwaite, Howell 2009; 47
Alladi, Xuereb, Bak 2007; 130
Collins, Montal, Hochberg 2017; 140
Lowe, Curran, Fang 2016; 4
Chare, Hodges, Leyton 2014; 85
Mormino, Betensky, Hedden 2014; 82
Mackenzie, Neumann, Baborie 2011; 122
Gomperts, Locascio, Makaretz 2016; 73
Hodges, Mitchell, Dawson 2010; 133
Bigio, Wu, Deng 2013; 125
2020050722281760000_89.10.1024.35
Josephs (2020050722281760000_89.10.1024.12) 2016; 132
2020050722281760000_89.10.1024.14
Sander (2020050722281760000_89.10.1024.17) 2016; 12
2020050722281760000_89.10.1024.37
2020050722281760000_89.10.1024.18
Ng (2020050722281760000_89.10.1024.36) 2017; 9
Coakeley (2020050722281760000_89.10.1024.13) 2016; 271678X
Mesulam (2020050722281760000_89.10.1024.3) 2017; 376
Marquié (2020050722281760000_89.10.1024.15) 2017; 81
2020050722281760000_89.10.1024.7
2020050722281760000_89.10.1024.6
2020050722281760000_89.10.1024.9
2020050722281760000_89.10.1024.8
2020050722281760000_89.10.1024.2
2020050722281760000_89.10.1024.5
2020050722281760000_89.10.1024.4
2020050722281760000_89.10.1024.30
2020050722281760000_89.10.1024.31
2020050722281760000_89.10.1024.32
2020050722281760000_89.10.1024.1
2020050722281760000_89.10.1024.11
2020050722281760000_89.10.1024.33
2020050722281760000_89.10.1024.24
2020050722281760000_89.10.1024.25
2020050722281760000_89.10.1024.26
2020050722281760000_89.10.1024.27
2020050722281760000_89.10.1024.28
2020050722281760000_89.10.1024.29
Lowe (2020050722281760000_89.10.1024.16) 2016; 4
Xia (2020050722281760000_89.10.1024.19) 2017; 74
Gomperts (2020050722281760000_89.10.1024.34) 2016; 73
2020050722281760000_89.10.1024.20
2020050722281760000_89.10.1024.21
Spinelli (2020050722281760000_89.10.1024.10) 2017; 81
2020050722281760000_89.10.1024.22
2020050722281760000_89.10.1024.23
References_xml – volume: 5
  start-page: 16404
  year: 2015
  article-title: Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
  publication-title: Sci Rep
  doi: 10.1038/srep16404
– volume: 81
  start-page: 430
  year: 2017
  article-title: Typical and atypical pathology in primary progressive aphasia variants
  publication-title: Ann Neurol
  doi: 10.1002/ana.24885
– volume: 14
  start-page: 11
  year: 2004
  article-title: Automatically parcellating the human cerebral cortex
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhg087
– volume: 75
  start-page: 358
  year: 2010
  article-title: Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181ea15e8
– volume: 125
  start-page: 463
  year: 2013
  article-title: Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-013-1089-6
– volume: 122
  start-page: 111
  year: 2011
  article-title: A harmonized classification system for FTLD-TDP pathology
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-011-0845-8
– volume: 271678X
  start-page: 0271678X1668369
  year: 2016
  article-title: Positron emission tomography imaging of tau pathology in progressive supranuclear palsy
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1177/0271678X16683695
– volume: 76
  start-page: 1006
  year: 2011
  article-title: Classification of primary progressive aphasia and its variants
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31821103e6
– volume: 81
  start-page: 117
  year: 2017
  article-title: Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies
  publication-title: Ann Neurol
  doi: 10.1002/ana.24844
– volume: 58
  start-page: 332
  year: 2017
  article-title: Reference Tissue-Based kinetic evaluation of 18F-AV-1451 for Tau Imaging
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.116.175273
– volume: 85
  start-page: 865
  year: 2014
  article-title: New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2013-306948
– volume: 9
  start-page: 25
  year: 2017
  article-title: Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-017-0253-y
– volume: 78
  start-page: 787
  year: 2015
  article-title: Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
  publication-title: Ann Neurol
  doi: 10.1002/ana.24517
– volume: 140
  start-page: 457
  year: 2017
  article-title: Focal temporal pole atrophy and network degeneration in semantic variant primary progressive aphasia
  publication-title: Brain
  doi: 10.1093/brain/aww313
– volume: 115
  start-page: 1783
  issue: Pt 6
  year: 1992
  article-title: Semantic dementia. progressive fluent aphasia with temporal lobe atrophy
  publication-title: Brain
– volume: 74
  start-page: 427
  year: 2017
  article-title: Association of In Vivo [18F]AV-1451 tau PET Imaging results with cortical atrophy and symptoms in typical and atypical alzheimer disease
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2016.5755
– volume: 12
  start-page: 1116
  year: 2016
  article-title: Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer’s disease, primary tauopathies, and other dementias
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2016.01.003
– volume: 349
  start-page: 1535
  year: 2003
  article-title: Primary progressive aphasia--a language-based dementia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra022435
– volume: 133
  start-page: 300
  year: 2010
  article-title: Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases
  publication-title: Brain
  doi: 10.1093/brain/awp248
– volume: 132
  start-page: 334
  year: 2016
  article-title: Different partial volume correction methods lead to different conclusions: an (18)F-FDG-PET study of aging
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2016.02.042
– volume: 376
  start-page: 158
  year: 2017
  article-title: Case 1-2017. A 70-Year-Old Woman with gradually progressive loss of language
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcpc1613459
– volume: 132
  start-page: 931
  year: 2016
  article-title: [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-016-1618-1
– volume: 139
  start-page: 1551
  year: 2016
  article-title: Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
  publication-title: Brain
  doi: 10.1093/brain/aww027
– volume: 47
  start-page: 2690
  year: 2009
  article-title: On comparing a single case with a control sample: an alternative perspective
  publication-title: Neuropsychologia
  doi: 10.1016/j.neuropsychologia.2009.04.011
– volume: 139
  start-page: 2372
  year: 2016
  article-title: 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
  publication-title: Brain
  doi: 10.1093/brain/aww163
– volume: 130
  start-page: 2636
  year: 2007
  article-title: Focal cortical presentations of Alzheimer’s disease
  publication-title: Brain
  doi: 10.1093/brain/awm213
– volume: 4
  start-page: 58
  year: 2016
  article-title: An autoradiographic evaluation of AV-1451 Tau PET in dementia
  publication-title: Acta Neuropathol Commun
  doi: 10.1186/s40478-016-0315-6
– volume: 79
  start-page: 110
  year: 2016
  article-title: Tau positron emission tomographic imaging in aging and early alzheimer disease
  publication-title: Ann Neurol
  doi: 10.1002/ana.24546
– volume: 57
  start-page: 1535
  year: 2016
  article-title: Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer Disease
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.115.170027
– year: 2013
  article-title: A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807
  publication-title: J Label Compd Radiopharm
– volume: 125
  start-page: 121
  year: 2013
  article-title: TDP-43 skeins show properties of amyloid in a subset of ALS cases
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-012-1055-8
– volume: 117
  start-page: 15
  year: 2009
  article-title: Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0460-5
– volume: 82
  start-page: 1760
  year: 2014
  article-title: Amyloid and APOE ε4 interact to influence short-term decline in preclinical alzheimer disease
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000000431
– volume: 73
  start-page: 1334
  year: 2016
  article-title: Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2016.3338
– volume: 89
  start-page: 971
  year: 2016
  article-title: PET Imaging of Tau Deposition in the Aging Human brain
  publication-title: Neuron
  doi: 10.1016/j.neuron.2016.01.028
– volume: 27
  start-page: 74
  year: 2013
  article-title: Patterns of striatal degeneration in frontotemporal dementia
  publication-title: Alzheimer Dis Assoc Disord
  doi: 10.1097/WAD.0b013e31824a7df4
– volume: 31
  start-page: 968
  year: 2006
  article-title: An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2006.01.021
– volume: 9
  start-page: 25
  year: 2017
  ident: 2020050722281760000_89.10.1024.36
  article-title: Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-017-0253-y
– ident: 2020050722281760000_89.10.1024.2
  doi: 10.1212/WNL.0b013e31821103e6
– ident: 2020050722281760000_89.10.1024.26
  doi: 10.1016/j.neuroimage.2016.02.042
– ident: 2020050722281760000_89.10.1024.30
  doi: 10.2967/jnumed.115.170027
– volume: 132
  start-page: 931
  year: 2016
  ident: 2020050722281760000_89.10.1024.12
  article-title: [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-016-1618-1
– volume: 81
  start-page: 117
  year: 2017
  ident: 2020050722281760000_89.10.1024.15
  article-title: Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies
  publication-title: Ann Neurol
  doi: 10.1002/ana.24844
– ident: 2020050722281760000_89.10.1024.24
  doi: 10.1002/jlcr.3098
– ident: 2020050722281760000_89.10.1024.25
  doi: 10.2967/jnumed.116.175273
– ident: 2020050722281760000_89.10.1024.29
  doi: 10.1002/ana.24546
– ident: 2020050722281760000_89.10.1024.27
  doi: 10.1016/j.neuroimage.2006.01.021
– ident: 2020050722281760000_89.10.1024.6
  doi: 10.1007/s00401-008-0460-5
– ident: 2020050722281760000_89.10.1024.8
  doi: 10.1093/brain/awp248
– ident: 2020050722281760000_89.10.1024.11
  doi: 10.1093/brain/aww163
– ident: 2020050722281760000_89.10.1024.20
  doi: 10.1212/WNL.0b013e3181ea15e8
– ident: 2020050722281760000_89.10.1024.1
  doi: 10.1093/brain/aww313
– ident: 2020050722281760000_89.10.1024.31
  doi: 10.1007/s00401-013-1089-6
– volume: 376
  start-page: 158
  year: 2017
  ident: 2020050722281760000_89.10.1024.3
  article-title: Case 1-2017. A 70-Year-Old Woman with gradually progressive loss of language
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcpc1613459
– ident: 2020050722281760000_89.10.1024.22
  doi: 10.1212/WNL.0000000000000431
– ident: 2020050722281760000_89.10.1024.9
  doi: 10.1136/jnnp-2013-306948
– ident: 2020050722281760000_89.10.1024.21
  doi: 10.1056/NEJMra022435
– ident: 2020050722281760000_89.10.1024.37
  doi: 10.1038/srep16404
– ident: 2020050722281760000_89.10.1024.35
  doi: 10.1097/WAD.0b013e31824a7df4
– volume: 81
  start-page: 430
  year: 2017
  ident: 2020050722281760000_89.10.1024.10
  article-title: Typical and atypical pathology in primary progressive aphasia variants
  publication-title: Ann Neurol
  doi: 10.1002/ana.24885
– volume: 4
  start-page: 58
  year: 2016
  ident: 2020050722281760000_89.10.1024.16
  article-title: An autoradiographic evaluation of AV-1451 Tau PET in dementia
  publication-title: Acta Neuropathol Commun
  doi: 10.1186/s40478-016-0315-6
– ident: 2020050722281760000_89.10.1024.18
  doi: 10.1093/brain/aww027
– volume: 74
  start-page: 427
  year: 2017
  ident: 2020050722281760000_89.10.1024.19
  article-title: Association of In Vivo [18F]AV-1451 tau PET Imaging results with cortical atrophy and symptoms in typical and atypical alzheimer disease
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2016.5755
– volume: 73
  start-page: 1334
  year: 2016
  ident: 2020050722281760000_89.10.1024.34
  article-title: Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2016.3338
– ident: 2020050722281760000_89.10.1024.23
  doi: 10.1093/cercor/bhg087
– ident: 2020050722281760000_89.10.1024.5
  doi: 10.1007/s00401-011-0845-8
– volume: 12
  start-page: 1116
  year: 2016
  ident: 2020050722281760000_89.10.1024.17
  article-title: Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer’s disease, primary tauopathies, and other dementias
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2016.01.003
– ident: 2020050722281760000_89.10.1024.33
  doi: 10.1016/j.neuron.2016.01.028
– ident: 2020050722281760000_89.10.1024.28
  doi: 10.1016/j.neuropsychologia.2009.04.011
– ident: 2020050722281760000_89.10.1024.4
  doi: 10.1093/brain/115.6.1783
– ident: 2020050722281760000_89.10.1024.32
  doi: 10.1007/s00401-012-1055-8
– volume: 271678X
  start-page: 0271678X1668369
  year: 2016
  ident: 2020050722281760000_89.10.1024.13
  article-title: Positron emission tomography imaging of tau pathology in progressive supranuclear palsy
  publication-title: J Cereb Blood Flow Metab
– ident: 2020050722281760000_89.10.1024.7
  doi: 10.1093/brain/awm213
– ident: 2020050722281760000_89.10.1024.14
  doi: 10.1002/ana.24517
SSID ssj0000089
Score 2.5157657
Snippet ObjectiveThe semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR...
The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding...
SourceID pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1024
SubjectTerms Age
Aged
Aged, 80 and over
Aging
Amyotrophic lateral sclerosis
Aphasia
Aphasia, Primary Progressive - diagnostic imaging
Aphasia, Primary Progressive - metabolism
Atrophy
Brain
Brain - diagnostic imaging
Brain - metabolism
Carbolines
Dementia
Disease
Female
Humans
Language
Magnetic Resonance Imaging
Male
Medical imaging
Middle Aged
Neurodegeneration
Neuroimaging
Neuropathology
NMR
Nuclear magnetic resonance
Pathology
Patients
Positron-Emission Tomography - methods
Semantics
tau Proteins - metabolism
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9QwDLfYkBAviO8VBgrSXnioLm0-mjwhhHaaECAeNuneorRNtU67Xtnd7e_HbnNlB9J4S9WmTW0n8c92bIATXRaFD5VNjdEilVnJUx9MMxzOkaZqSl4P0RY_9NmF_LpQi2hwW8ewyt2aOCzU9aoiG_kMgQru7SiQ8lP_K6WqUeRdjSU0DuAhpS4j8FUsijvqr7FTtnCu-M5NKfTsqut6lJCMjHRaUjjiQbm82t-c_tE4_w6cvLMTzZ_Ck6hCss8jz5_Bg9A9h0ffo5P8BXybX5NOva3avr1h2GA_T89ZuxzqEbG2Y-uwRHq2FbtFoIwt1o8pJ9gQrEVxsbeB-f6SDli-hIv56fmXszQWTUhLlesNLhiiQeDZSMRdwmhZc-9pktWF95zXpQmiQI06E1KpBuELXtrSIm5SSlvZCPEKDrtVF46A8bxSuQw8D4WRxlubZ3WgFG0ir42sdQInSDMXx-gGOCG0I9I6Iq0bSZvAbEdUV8XE41T_4vqeHh-nHv9_-_GOTy5Ov7X7IywJfJhu48Qhb4jvwmq7dpklrGYRoSfwemTr9DFEoYby6idQ7DF8eoCScu_f6drLITm3sjgqqd7cP6y38Bj_wYy2nGM43NxswzvUbjbl-0GEfwNvEPS0
  priority: 102
  providerName: ProQuest
Title Flortaucipir tau PET imaging in semantic variant primary progressive aphasia
URI https://jnnp.bmj.com/content/89/10/1024.full
https://www.ncbi.nlm.nih.gov/pubmed/28986472
https://www.proquest.com/docview/2115140734
https://www.proquest.com/docview/1948759383
https://pubmed.ncbi.nlm.nih.gov/PMC5964045
Volume 89
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB4VkKpeKvpOoStX4tJDhBM_Yh8p2hVCXYSqpdqerDwcEcSGFbvL7-9Mkk1ZigqnOHLsODN-zJcZfwY40FmSpD63oTFahDLKeJh6Uzabc6TJy4wXTbTFmT65kKdTNf1Lk_PAgx8JfXhV13PUZUS_07SkvXo7RMlCQMv-ntwzdY3tmcG54muX5CM1EAGwIVpyogXeymZXm2vSP4bmw3jJewvQaBded5YjO2pV_QZe-PotvBx3vvF38GN0Tab0Kq_m1S3DBDsfTlg1a44hYlXNFn6GYqxydof4GFNs3jJNsCZGi8Jh7zxL55e0r_I9XIyGk-OTsDsrIcxUrJc4T4gS8WYpEW4J_LSCpymNrSJJU86LzHiRoCEdCalUiagFb21mES4ppa0shfgA2_VN7T8B43GuYul57BMjTWptHBWemNlEXBhZ6AAOUGaua6NrUITQjqTsSMqulXIAh2uhurzjG6djL67_U-JbX-Lp2vfXenLdqFs4BLNo_-GkJQP42mfjeCEnSFr7m9XCRZYgmkVgHsDHVq39y9a9IoBkQ-H9A8TFvZlTV5cNJ7ey2CqpPj9PNnvwCu9aXt1oH7aXtyv_BY2bZTaArWSaDJq-PYCdo-Px-Bdevw_Pzn_-AQIQ8iQ
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkaAXxLMNtGCkcuAQrRM_Yh8QQqWrLd1WHLbS3kwejpqqmw3d3SL-FL-RmbzoglROvTlKnDjzsOfzjGcI2VdJFMUuNb7WivsiSJgfO53Xh3OETvOEZXW0xakanYkvUzndIL-6szAYVtnNifVEnc1T3CMfAFCBtR0EUnysvvtYNQq9q10JjUYsjt3PHwDZFh-OPgN_34Xh8HByMPLbqgJ-IkO1BI3iOSCzXAAw4VqJjMUxSmEWxTFjWaIdj8DkDLiQMgf7Hi5NYgBYSKmMyHEDFKb8-7DwMgwhjKbRDXNbmz47OZOsc4tyNbgoywokMsBNQSUw_PFeMrtYXwz_sXD_DtS8sfINH5NHrclKPzUy9oRsuPIpeXDSOuWfkfHwEm34VVpUxRWFBv16OKHFrK5_RIuSLtwM-Fek9BqAObRo1aS4oHVwGMbhXjsaV-d4oPM5ObsTcr4gm-W8dDuEsjCVoXAsdJEWOjYmDDKHKeF4mGmRKY_sA81sO0ZbwxeuLJLWImltQ1qPDDqi2rRNdI71Ni5v6fG-7_H_t-92fLKtui_sH-H0yNv-Nigqel_i0s1XCxsYxIaGa-6R7Yat_ccA9WrM4--RaI3h_QOYBHz9Tlmc18nApYFRCfny9mG9IQ9Hk5OxHR-dHr8iW_A_TVLfYJdsLq9Wbg8sq2XyuhZnSr7dtf78Bt4eLkg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcUHmHFjBSOXCINokfsQ8IIdpVS0vVQyvtzeThqKm62dDdLeKv8euYyYsuSOXUm6PEiTMPez7PeAZgR6VxnLjM-For7oswDfzE6aI5nCN0VqRB3kRbHKv9M_FlIidr8Ks_C0Nhlf2c2EzU-SyjPfIRAhVc21EgxajowiJOdscf6-8-VZAiT2tfTqMVkUP38wfCt_mHg13k9bsoGu-dft73uwoDfiojtUDt4gWitEIgSOFaiTxIEpLIPE6SIMhT7XiM5mfIhZQF2vp4aVKDIENKZURBm6E4_d-POS6bqEvxJL5hemszZCoPZNC7SLkaXVRVjdIZ0gahEhQKeS-dXqwujP9Yu38Hbd5YBceb8LAzX9mnVt4ewZqrHsPG185B_wSOxpdkzy-zsi6vGDbYyd4pK6dNLSRWVmzupsjLMmPXCNKxxeo23QVrAsUoJvfasaQ-p8OdT-HsTsj5DNarWeVeAAuiTEbCBZGLtdCJMVGYO0oPx6Nci1x5sIM0s90YbQNluLJEWkuktS1pPRj1RLVZl_Scam9c3tLj_dDj_2_f7vlkO9Wf2z-C6sHb4TYqLXliksrNlnMbGsKJhmvuwfOWrcPHEAFryunvQbzC8OEBSgi-eqcqz5vE4NLgqIR8efuw3sAGao49Ojg-3IIH-Dttft9wG9YXV0v3Co2sRfq6kWYG3-5afX4DN3gyfg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flortaucipir+tau+PET+imaging+in+semantic+variant+primary+progressive+aphasia&rft.jtitle=Journal+of+neurology%2C+neurosurgery+and+psychiatry&rft.au=Makaretz%2C+Sara+J&rft.au=Quimby%2C+Megan&rft.au=Collins%2C+Jessica&rft.au=Makris%2C+Nikos&rft.date=2018-10-01&rft.issn=0022-3050&rft.eissn=1468-330X&rft.volume=89&rft.issue=10&rft.spage=1024&rft_id=info:doi/10.1136%2Fjnnp-2017-316409&rft_id=info%3Apmid%2F28986472&rft.externalDBID=jnnp&rft.externalDocID=jnnp
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3050&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3050&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3050&client=summon